Cargando…

Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?

Detalles Bibliográficos
Autores principales: Deng, Jie-Lin, Jiang, Yun-Qiu, Guo, Yan-Kai, Li, Hong-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647493/
https://www.ncbi.nlm.nih.gov/pubmed/32804730
http://dx.doi.org/10.1097/CM9.0000000000000996
_version_ 1783606919376666624
author Deng, Jie-Lin
Jiang, Yun-Qiu
Guo, Yan-Kai
Li, Hong-Liang
author_facet Deng, Jie-Lin
Jiang, Yun-Qiu
Guo, Yan-Kai
Li, Hong-Liang
author_sort Deng, Jie-Lin
collection PubMed
description
format Online
Article
Text
id pubmed-7647493
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-76474932020-11-20 Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations? Deng, Jie-Lin Jiang, Yun-Qiu Guo, Yan-Kai Li, Hong-Liang Chin Med J (Engl) Editorials Lippincott Williams & Wilkins 2020-11-20 2020-08-13 /pmc/articles/PMC7647493/ /pubmed/32804730 http://dx.doi.org/10.1097/CM9.0000000000000996 Text en Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Editorials
Deng, Jie-Lin
Jiang, Yun-Qiu
Guo, Yan-Kai
Li, Hong-Liang
Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?
title Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?
title_full Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?
title_fullStr Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?
title_full_unstemmed Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?
title_short Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?
title_sort patients taking angiotensin-converting enzyme inhibitors/angiotensin ii type i receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647493/
https://www.ncbi.nlm.nih.gov/pubmed/32804730
http://dx.doi.org/10.1097/CM9.0000000000000996
work_keys_str_mv AT dengjielin patientstakingangiotensinconvertingenzymeinhibitorsangiotensiniitypeireceptorblockershigherrisksofsevereacuterespiratorysyndromecoronavirus2infectionbutmilderclinicalmanifestations
AT jiangyunqiu patientstakingangiotensinconvertingenzymeinhibitorsangiotensiniitypeireceptorblockershigherrisksofsevereacuterespiratorysyndromecoronavirus2infectionbutmilderclinicalmanifestations
AT guoyankai patientstakingangiotensinconvertingenzymeinhibitorsangiotensiniitypeireceptorblockershigherrisksofsevereacuterespiratorysyndromecoronavirus2infectionbutmilderclinicalmanifestations
AT lihongliang patientstakingangiotensinconvertingenzymeinhibitorsangiotensiniitypeireceptorblockershigherrisksofsevereacuterespiratorysyndromecoronavirus2infectionbutmilderclinicalmanifestations